Evolving strategies to overcome endocrine resistance in breast cancer

被引：0
|
作者：
Hubalek M. [1 ]
Brunner C. [1 ]
Marth C. [1 ]
机构：
[1] Department of Obstetrics and Gynecology, Brustgesundheitzentrum Tirol, Innsbruck Medical University, 6020 Innsbruck
来源：
memo - Magazine of European Medical Oncology | 2012年 / 5卷 / 2期
关键词：
Breast cancer; EGFR; Endocrine resistance; Farnesyltransferase inhibitors; HER2; Histone deacetylases inhibitors; IGF-R inhibitiors; MTOR-inhibitor; SRC-inhibitor;
D O I：
10.1007/s12254-012-0003-6
中图分类号：
学科分类号：
摘要：
Endocrine therapies targeting estrogen action decrease mortality from breast cancer, but their efficacy is limited by intrinsic and acquired therapeutic resistance. Various mechanisms can contribute to insensitivity toward endocrine treatment in hormone receptorpositive breast cancer patients. Definition of the specific genetic lesions and molecular processes that determine clinical endocrine resistance is still incomplete but recently tremendous advances have been made. In this short review the latest strategies to overcome endocrine resistance will be discussed. © Springer-Verlag Wien 2012.
引用
收藏
页码：105 / 109
页数：4
相关论文
共 50 条
  • [21] Endocrine-responsive breast cancer and strategies for combating resistance
    Ali, S
    Coombes, RC
    NATURE REVIEWS CANCER, 2002, 2 (02) : 101 - +
  • [22] New strategies to overcome resistance to mammalian target of rapamycin inhibitors in breast cancer
    Vicier, Cecile
    Dieci, Maria V.
    Andre, Fabrice
    CURRENT OPINION IN ONCOLOGY, 2013, 25 (06) : 587 - 593
  • [23] Endocrine resistance in metastatic breast cancer: Mechanisms and new therapeutic strategies
    Schiff, Rachel
    Veeraraghavan, Jamunarani
    Fu, Xiaoyong
    CANCER RESEARCH, 2018, 78 (13)
  • [24] Endocrine resistance in breast cancer: from molecular mechanisms to therapeutic strategies
    Saatci, Ozge
    Huynh-Dam, Kim-Tuyen
    Sahin, Ozgur
    JOURNAL OF MOLECULAR MEDICINE-JMM, 2021, 99 (12): : 1691 - 1710
  • [25] Endocrine resistance in breast cancer: from molecular mechanisms to therapeutic strategies
    Ozge Saatci
    Kim-Tuyen Huynh-Dam
    Ozgur Sahin
    Journal of Molecular Medicine, 2021, 99 : 1691 - 1710
  • [26] Endocrine resistance in breast cancer
    Zheng, L. H.
    Zhao, Y. H.
    Feng, H. L.
    Liu, Y. J.
    CLIMACTERIC, 2014, 17 (05) : 522 - 528
  • [27] Inhibition of β-Catenin to Overcome Endocrine Resistance in Tamoxifen-Resistant Breast Cancer Cell Line
    Won, Hye Sung
    Lee, Kyung Mee
    Oh, Ju Eon
    Nam, Eun Mi
    Lee, Kyoung Eun
    PLOS ONE, 2016, 11 (05):
  • [28] Clinical trials of intracellular signal transductions inhibitors for breast cancer - a strategy to overcome endocrine resistance
    Johnston, SRD
    ENDOCRINE-RELATED CANCER, 2005, 12 : S145 - S157
  • [29] Increasing DAXX Expression in ER plus Breast Cancer Cells to Overcome Endocrine Therapy Resistance
    Osipo, Clodia
    Albain, Kathy S.
    Peiffer, Daniel
    Wyatt, Debra
    CANCER RESEARCH, 2023, 83 (05)
  • [30] Therapeutic strategies to overcome taxane resistance in cancer
    Das, Tuyelee
    Anand, Uttpal
    Pandey, Swaroop Kumar
    Ashby, Charles R., Jr.
    Assaraf, Yehuda G.
    Chen, Zhe-Sheng
    Dey, Abhijit
    DRUG RESISTANCE UPDATES, 2021, 55
12345